QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors

2021/05/11 by Ahmed Adebayo Ishola, Oluwaseye Adedirin, Tanuja Joshi +1 · 8 citations
Chemistry · Computer Science · Medicine · #ADME #Biochemistry #Biology #Chemistry #Computational Drug Discovery Methods #Computational biology #Coronavirus #Coronavirus disease 2019 (COVID-19) #Docking (animal) #Drug discovery #Enzyme #In silico #In vitro #Lipinski's rule of five #Medicine #Protease #Quantitative structure–activity relationship #Stereochemistry #Synthesis and biological activity #chEMBL #thermodynamics and calorimetric analyses

paper · doi:10.1016/j.compbiomed.2021.104483

openalex publication_date 2021/05/11 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05

Cited by

• Bio-activity prediction of drug candidate compounds targeting SARS-Cov-2 using machine learning approaches. [europepmc]
• Recent advances in chemometric modelling of inhibitors against SARS-CoV-2. [europepmc]
• Unveiling the antiviral inhibitory activity of ebselen and ebsulfur derivatives on SARS-CoV-2 using machine learning-based QSAR, LB-PaCS-MD, and experimental assay. [europepmc]
• A Data-Driven Approach for Interpretable and Efficient Predictive Modeling: A Case Study in SARS-CoV-2 Protease Inhibitor Discovery Through Feature Selection. [europepmc]
• In silico prediction of the inhibition of new molecules on SARS-CoV-2 3CL protease by using QSAR: PSOSVR approach [europepmc]
• In silico prediction of the inhibition of new molecules on 3CLpro SARS-CoV-2 enzyme by using QSAR-SVRPSO approach [europepmc]
• Predicting the Activity of Molecules against SARS-CoV-2 using Machine Learning Techniques and Stacked Generalization [europepmc]
• Predicting the Activity of Molecules Against SARS-CoV-2 Using Machine Learning Techniques and Stacked Generalization [europepmc]